OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 143 citing articles:

EMT‐associated microRNAs and their roles in cancer stemness and drug resistance
Guangtao Pan, Yuhan Liu, Luorui Shang, et al.
Cancer Communications (2021) Vol. 41, Iss. 3, pp. 199-217
Open Access | Times Cited: 246

Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer
Chang Li, Liang Wan, Zeyi Liu, et al.
Cancer Letters (2018) Vol. 418, pp. 185-195
Closed Access | Times Cited: 159

LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma
Dong‐Mei Wu, Shan Wang, Xin Wen, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 10
Open Access | Times Cited: 143

The roles of ZEB1 in tumorigenic progression and epigenetic modifications
Yu Zhang, Lei Xu, Anqi Li, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 110, pp. 400-408
Open Access | Times Cited: 128

Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
Cellular Signalling (2020) Vol. 78, pp. 109871-109871
Closed Access | Times Cited: 122

Estrogen receptor β promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer
Weiwei Yu, Jie Ding, Maio He, et al.
Oncogene (2018) Vol. 38, Iss. 8, pp. 1225-1238
Closed Access | Times Cited: 101

A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer
Jinchang Pan, Chengwei Zhou, Xiaodong Zhao, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 96

The crucial role of ZEB2: From development to epithelial‐to‐mesenchymal transition and cancer complexity
Masoumeh Fardi, Mohammad Reza Alivand, Behzad Baradaran, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 9, pp. 14783-14799
Closed Access | Times Cited: 92

MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7
Yuanyuan Ye, Jiawei Mei, Shanshan Xiang, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 3
Open Access | Times Cited: 91

MicroRNAs in lung cancer
Diana Castro, Márcia Zabdiele Moreira, Alexandra Gouveia, et al.
Oncotarget (2017) Vol. 8, Iss. 46, pp. 81679-81685
Open Access | Times Cited: 90

Molecular mechanisms of epithelial to mesenchymal transition in tumor metastasis
Artur Nieszporek, Klaudia Skrzypek, Grażyna Adamek, et al.
Acta Biochimica Polonica (2019)
Open Access | Times Cited: 85

Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment
Qian Yu, Minda Zhang, Qidi Ying, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 3
Open Access | Times Cited: 80

A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay
Ahmed S. Doghish, Ahmed Ismail, Mahmoud A. Elrebehy, et al.
Pathology - Research and Practice (2022) Vol. 237, pp. 154053-154053
Closed Access | Times Cited: 69

MiRNA-mediated EMT and CSCs in cancer chemoresistance
Bing Dong, Shiyu Li, Shuangli Zhu, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 65

Role of STAT3 in cancer cell epithelial‑mesenchymal transition (Review)
Guoan Zhang, Sen Hou, Shuyue Li, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 5
Open Access | Times Cited: 13

MicroRNAs associated with therapy of non-small cell lung cancer
Junmi Lu, Yuting Zhan, Juan Feng, et al.
International Journal of Biological Sciences (2018) Vol. 14, Iss. 4, pp. 390-397
Open Access | Times Cited: 81

Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer
Chengfei Jiang, Zhumei Shi, Dongmei Li, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 80

miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling
Dongmin Shi, Lixin Li, Xinyu Bian, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 78

miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC
Xiaoyuan Wang, Qingwei Meng, Wenbo Qiao, et al.
Stem Cell Research & Therapy (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 71

MicroRNA in Lung Cancer Metastasis
Shang‐Gin Wu, Tzu‐Hua Chang, Yinan Liu, et al.
Cancers (2019) Vol. 11, Iss. 2, pp. 265-265
Open Access | Times Cited: 66

Frontiers of MicroRNA Signature in Non-small Cell Lung Cancer
Xinping Zhu, Masahisa Kudo, Xiangjie Huang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 51

Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer
Priya Mondal, Syed Musthapa Meeran
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17

Page 1 - Next Page

Scroll to top